Massive Bio

Massive Bio

Clinical Trials & Research

About Massive Bio

Massive Bio is a precision oncology company that leverages artificial intelligence to revolutionize cancer clinical trial access and patient recruitment. The company's Synergy AI Platform connects cancer patients with clinical trials regardless of their location or financial circumstances, bringing together physicians, drug developers, hospitals, and genomic companies in a comprehensive ecosystem. The platform analyzes over 500 medical data elements from patient records to match individuals with suitable trials from a database of 19,000+ active interventional cancer clinical trials worldwide. Massive Bio serves multiple stakeholders through specialized solutions: Patient Connect empowers patients and caregivers to navigate their clinical trial journey, Trial Relay enables physicians to seamlessly refer patients for trial matching, Reticulum Nexus supports clinical operations teams with AI-enabled multi-trial matching, and Trial Vision provides pharma and CRO clients with real-time recruitment analytics. The company has onboarded over 200,000 cancer patients and operates across 45+ markets globally, partnering with patient advocacy organizations, pharmaceutical companies, and healthcare institutions. Massive Bio combines AI technology with human expertise from oncology nurses and physicians to deliver personalized trial matching reports within 24 hours, while maintaining strict compliance with HIPAA, GDPR, PIPEDA, SOC 2 Type II, and PCI-DSS standards.

Mission & Story

Mission

We connect cancer patients with clinical trials, regardless of their location or finances, using an AI-powered platform that brings together physicians, drug developers, hospitals, and genomic companies.

Clinical Focus

Medical conditions and clinical areas addressed by Massive Bio.

Breast CancerCervical CancerColorectal CancerEndometrial CancerGastrointestinal Stromal TumorHead & Neck CancerLeukemiaLung CancerLymphomaMultiple MyelomaMyelodysplastic SyndromesMyelofibrosisNon Small Cell Lung CancerOvarian CancerPancreatic CancerRectal CancerSmall Cell Lung CancerChronic Myeloid LeukemiaNeuroblastomaMelanomaLiver CancerPediatric Cancer

Who It Serves

Patients and CaregiversPhysiciansPharmaCROsHealth SystemsPatient Advocacy Organizations

Milestones & Awards

Recent Milestones

Launched Nexus Pulse AI-native market intelligence platform for biopharma commercial teams; created 'Little Tales for Massive Heroes' therapeutic storybook for pediatric cancer support; attending ASCO 2026

Key Partnerships

Patient Advocacy OrganizationsPharmaceutical companiesContract Research Organizations (CROs)HospitalsGenomic companies

Company Details

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

HIPAAGDPRPIPEDASOC 2 Type IIPCI-DSS
Last updated Jun 30, 2026

Similar Companies in this Market

View all 42
AiCure

AiCure

AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.

Antidote

Antidote

Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.

BEKhealth

BEKhealth

BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.

BenevolentAI

BenevolentAI

public · 180 employees

BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.

Biorce

Biorce

Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.

BIOS Health

BIOS Health

BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.

Castor

Castor

Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.

Circuit Clinical

Circuit Clinical

Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.